Combination Of Sildenafil To Bosentan Therapy In Patients With Pulmonary Arterial Hypertension Associated With Congenital Heart Defects

被引：0
|
作者：
Beciani, E.
Leci, E.
Palazzini, M.
Bachetti, C.
Sciarra, F.
Conficoni, E.
Manes, A.
Galie, N.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5895
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Bosentan therapy in patients with pulmonary hypertension secondary to congenital heart disease (Eisenmenger physiology)
    D'Alto, M
    Sarubbi, B
    Vizza, CD
    Romeo, E
    Santoro, G
    Argiento, P
    Russo, MG
    Calabrò, R
    [J]. CHEST, 2005, 128 (04) : 366S - 366S
  • [42] Epoprostenol, bosentan and sildenafil combination for pulmonary arterial hypertension (PAH) in Eisenmenger syndrome: a case report
    Roustit, Matthieu
    Trivin, Caroline
    Allenet, Benoit
    Pison, Christophe
    Calop, Jean
    [J]. PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 508 - 508
  • [43] Adult patients with congenital heart disease and pulmonary arterial hypertension: First open prospective multicenter study of bosentan therapy
    Schulze-Neick, I
    Gilbert, N
    Ewert, R
    Witt, C
    Gruenig, E
    Enke, B
    Borst, MM
    Lange, PE
    Hoeper, MM
    [J]. AMERICAN HEART JOURNAL, 2005, 150 (04) : 716.e7 - 716.e12
  • [44] Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats
    Clozel, M
    Hess, P
    Rey, M
    Iglarz, M
    Binkert, C
    Qiu, CB
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (06) : 967 - 973
  • [45] Efficacy and Safety of Bosentan for Pulmonary Arterial Hypertension in Adults With Congenital Heart Disease
    Monfredi, Oliver
    Griffiths, Linda
    Clarke, Bernard
    Mahadevan, Vaikom S.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (10): : 1483 - 1488
  • [46] Sildenafil therapy for patients with porto-pulmonary hypertension and pulmonary arterial hypertension associated with HIV infection
    Negro, L.
    Palazzini, M.
    Manes, A.
    Leci, E.
    Conficoni, E.
    Marinelli, A.
    Bachetti, C.
    Beciani, E.
    Branzi, A.
    Galie', N.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 264 - 264
  • [47] Sildenafil therapy for patients with porto-pulmonary hypertension and pulmonary arterial hypertension associated with HIV infection
    Rizzo, N.
    Palazzini, M.
    Leci, E.
    Manes, A.
    Sgro, F.
    Sciarra, F.
    Bachetti, C.
    Beciani, E.
    Branzi, A.
    Galie, N.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 173 - 174
  • [48] Macitentan superior to bosentan in pulmonary arterial hypertension due to congenital heart disease?
    Blok, I. M.
    Van Riel, A. C. M. J.
    Schuuring, M. J.
    De Bruin-Bon, R. H. A. C. M.
    Van Dijk, A. P. J.
    Zwinderman, A. H.
    Mulder, B. J. M.
    Bouma, B. J.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 458 - 458
  • [49] Effect of pulmonary arterial hypertension specific therapy in the four clinical subgroups of patients with pulmonary arterial hypertension associated with congenital heart disease
    Monti, E.
    Rinaldi, A.
    Dardi, F.
    Palazzini, M.
    Gotti, E.
    Albini, A.
    Zuffa, E.
    Guarino, D.
    Pasca, F.
    De Lorenzis, A.
    Cassani, A.
    Orzalkiewicz, M.
    Manes, A.
    Galie, N.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 731 - 731
  • [50] Effect of Pulmonary Arterial Hypertension Specific Therapy in the Four Clinical Subgroups of Patients with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Palazzini, M.
    Manes, A.
    Dardi, F.
    Gotti, E.
    Rinaldi, A.
    Cassani, A.
    Zuffa, E.
    Guarino, D.
    De Lorenzis, A.
    Pasca, F.
    Magnani, I.
    Rotunno, M.
    Galie, N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345